An Open, Randomized, Multicenter Study of the Safety, Tolerability, & Immunogenicity of VAQTA™ Given Concomitantly With PROQUAD™ and PREVNAR™ in Healthy Children 12 Months of Age
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary) ; MMR-varicella zoster virus vaccine; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Chickenpox; Hepatitis A; Measles; Mumps; Pneumococcal infections; Rubella
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 18 Nov 2008 Official title and actual patient number updated.
- 27 Oct 2008 Trial end date changed from 1 Mar 2008 to 1 May 2008 as reported by Clinicaltrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.